In Andover, a Welcome Mat for Biotech Growth
Andover already has about 2 million square feet of building space devoted to life sciences, and is looking to add even more.
Pfizer Begins Trials of Omicron Booster
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
Second COVID Vaccine Shows Overwhelming Success
Cambridge-based pharmaceutical company Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.
Pfizer to Seek Emergency OK for COVID Vaccine
Pfizer and its partner BioNTech announced Monday morning that its vaccine candidate was more than 90 percent effective in preventing COVID-19
Pfizer Spinoff Joins Cambridge Crossing Migration
A Pfizer spinoff has leased nearly 60,000 square feet at Cambridge Crossing, which has now leased 1.3 million square feet to office and lab tenants.
Bulfinch, Partner Buy Piece of MIT Property in $1.1B Deal
Massachusetts Institute of Technology is selling a partial ownership of its 1 Portland St. and 610 and 700 Main St. office and lab buildings to Boston-based Bulfinch Cos. and Harrison Street Capital in a deal valued at $1.1 billion, or $1,626 per square foot.
Pfizer Expands Andover Campus With $200M Biotech Manufacturing Center
Pfizer’s campus in North Andover is expanding with the completion of its new 175,000-square-foot facility for developing and manufacturing complex biologics and vaccines.
Biotech Company Outgrows Incubator Space, Relocates To Alewife
Unum Therapeutics has relocated and expanded to...
Former Pfizer Lab In Alewife Sold For $165.5M
Cambridge-based King Street Properties has sold its...
